Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus-2009-2010

被引：0
|
作者：
Skrahina, Alena [1 ]
Khaliaukin, Andrei [2 ]
Falzon, Dennis [3 ]
Rusovich, Valiantsin [4 ]
Dara, Masoud [5 ]
Shyrayeu, Aliaksandr [2 ]
Zhylevich, Liudmila [6 ]
Zignol, Matteo [3 ]
Hurevich, Hennadz [1 ]
机构：
[1] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS
[2] Gomel Reg TB Hosp, Gomel, BELARUS
[3] World Hlth Org, STOP TB Dept, Geneva, Switzerland
[4] World Hlth Org, Country Off, Minsk, BELARUS
[5] World Hlth Org, Reg Off Europe, Copenhagen, Denmark
[6] Minist Hlth, Gen Directorate Med Care, Minsk, BELARUS
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Tuberculosis; -; management; MDR-TB; Monitoring;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2570
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
    Skrahina, Alena
    Hurevich, Henadz
    Zalutskaya, Aksana
    Sahalchyk, Evgeni
    Astrauko, Andrei
    Hoffner, Sven
    Rusovich, Valiantsin
    Dadu, Andrei
    de Colombani, Pierpaolo
    Dara, Masoud
    Van Gemert, Wayne
    Zignol, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus
    Khaliaukin, A.
    Kumar, A. M. V.
    Skrahina, A.
    Hurevich, H.
    Rusovich, V.
    Gadoev, J.
    Falzon, D.
    Khogali, M.
    De Colombani, P.
    PUBLIC HEALTH ACTION, 2014, 4 : S24 - S28
  • [3] Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
    Ormerod, LP
    BRITISH MEDICAL BULLETIN, 2005, 73-74 : 17 - 24
  • [4] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
  • [5] Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
    Mehari, Kibriti
    Asmelash, Tsehaye
    Hailekiros, Haftamu
    Wubayehu, Tewolde
    Godefay, Hagos
    Araya, Tadele
    Saravanan, Muthupandian
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2019, 2019
  • [6] Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
    Taylor, Holly A.
    Dowdy, David W.
    Searle, Alexandra R.
    Stennett, Andrea L.
    Dukhanin, Vadim
    Zwerling, Alice A.
    Merritt, Maria W.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [7] Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region
    Karaman, Onur
    Varol, Yelda
    Bicmen, Can
    Akarca, Tulay
    Dereli, Sevket
    Ozbakir, Didem
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [8] Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Kibuule, Dan
    Godman, Brian
    Hassali, Mohamed Azmi
    Ali, Hamdan Mustafa Hamdan
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (11) : 927 - 937
  • [9] Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Hassali, Mohamed Azmi
    Kibuule, Dan
    Godman, Brian
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [10] Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
    Field, Stephen K.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 137 - 149
12345